Concepedia

Catherine Rogers

CR

Statistics

Publications

34

Citations

3.3K

H-Index

30

Active since

1997

Affiliations

University of Oxford(Current)

Jenner Institute

Goethe University Frankfurt

Genomics (United Kingdom)

Genomics England

Catherine Rogers is an author at University of Oxford specializing in drug discovery, bromodomain proteins, and medicinal chemistry.

ORCID

Publications per year

1997–2024

34

Publications

34

<i>E2f3</i> is critical for normal cellular proliferation

Patrick O. Humbert, Raluca Verona, Jeffrey M. Trimarchi et al. · Genes & Development · 2000 · 346 citations · Full text

, , +13

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

Duncan A. Hay, Oleg Fedorov, Sarah Martin et al. · Journal of the American Chemical Society · 2014 · 285 citations · Full text

, , +17

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 224 citations · Full text

, , +13

E2F4 Is Essential for Normal Erythrocyte Maturation and Neonatal Viability

Patrick O. Humbert, Catherine Rogers, Soula Ganiatsas et al. · Molecular Cell · 2000 · 192 citations · Full text

, , +12

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

Peter G. K. Clark, Lucas Campos Curcino Vieira, C. Tallant et al. · Angewandte Chemie International Edition · 2015 · 164 citations · Full text

, , +15

1–5 of 34